Latest - HIV/AIDS

• Topol: US Betrays Healthcare Workers in Coronavirus Disaster Many US healthcare workers started this year already suffering from burnout, but the worst was yet to come.
  Medscape, March 30, 2020
• Challenges to Viral Suppression Among Children With HIV What do we currently know about the time to and durability of viral suppression after the initiation of cART among children living with HIV? Are certain factors associated with viral rebound?
  AIDS, March 30, 2020
• PrEP Implementation Behaviors of HIV Testing Staff How consistent are staff who provide community-based HIV testing in their PrEP implementation behaviors?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 30, 2020
• Fighting COVID-19: 'Everyone Can Do Something' Healthcare professionals in specialty clinics may be wondering how they can help during the COVID-19 pandemic. Dr Jessica Sparks Lilley shares her thoughts.
  Medscape Diabetes & Endocrinology, March 28, 2020
• Less Pain With Cancer Drug to Treat Anal HPV, but It's Expensive Pomalidomide is potentially a less painful alternative to options such as freezing and laser ablation, and it may have a lower rate of recurrence, but copays cost about $5000 for a month's supply.
  Medscape Medical News, March 27, 2020
• Medical Meetings May Be Forever Changed COVID-19 has caused medical conferences to be canceled this spring. Some regular attendees are expressing relief. Will this disruption lead to lasting changes?
  Medscape Medical News, March 27, 2020
• Mylan Waives Exclusive U.S. Distribution Rights for Potential COVID-19 Therapy U.S. drugmaker Mylan NV said on Wednesday it had waived its exclusive U.S. distribution rights to its generic version of HIV treatment Kaletra, which is currently being tested against the coronavirus.
  Reuters Health Information, March 25, 2020
• Safety of TAF in Patients With Tubulopathy on TDF Is tenofovir alafenamide a safe and effective option for HIV patients with a history of tenofovir disoproxil fumarate-associated tubulopathy?
  HIV Medicine, March 25, 2020
• Planning and Implementing a Transgender Health Program This article outlines the steps needed to effectively implement a transgender health program within a primary care practice.
  Annals of Family Medicine, March 24, 2020
• 7 Tips for Running Your Practice in the Coronavirus Crisis Experts provide key insight to keep your staff, patients, and business safe during the pandemic.
  Medscape Business of Medicine, March 23, 2020
• Drug Price Growth Expected to Slow in US and Worldwide: Report Utilization and spending growth will also rise less quickly than in the past decade, according to an IQVIA Institute report.
  Medscape Medical News, March 23, 2020
• Hydroxychloroquine Touted by Trump Already in Shortage - Pharmacists
  Reuters Health Information, March 19, 2020
• HIV Drug Combo Fails as Treatment for Severe COVID-19 in China Study
  Reuters Health Information, March 19, 2020
• Israel OKs Use of Generic Abbott Drug to Treat Coronavirus Despite Patent
  Reuters Health Information, March 19, 2020
• Alert Match Day Sets New Record, Celebrations Muted by COVID-19 A record 40,084 US and international applicants listed program choices for 37,256 positions, the most ever offered in the Match.
  News Alerts, March 20, 2020
• Should Docs Steer Clear of TikTok?   Drs Alok Patel, Danielle Jones, and Austin Chiang discuss the use of TikTok to share health information with a younger audience base.
  Medscape Hospital Medicine, March 20, 2020
• ID Specialist Diagnosed With COVID-19 in 'Ironic Twist' The Conference on Retroviruses and Opportunistic Infections went virtual last week to prevent the spread of coronavirus, but one of the organizers was diagnosed with it after the move.
  Medscape Medical News, March 19, 2020
• HIV Testing Underused for Adolescents With Acute STIs Adolescents with acute sexually transmitted infections (STIs) commonly do not undergo guideline-recommended HIV testing, according to a new study.
  Reuters Health Information, March 17, 2020
• Asian, Black Men With HIV Less Likely to Get Anal-Cancer Screening Asian men with HIV are much less likely than their white peers to have discussed anal-cancer screening with a healthcare provider, new findings from Canada show.
  Reuters Health Information, March 16, 2020
• Johnson & Johnson Says No Evidence HIV Drug Works Against Coronavirus Johnson & Johnson said on Monday said on Monday there is no evidence its HIV drug, Prezista, had any effect against the coronavirus, in response to reports that the drug could inhibit the virus.
  Reuters Health Information, March 16, 2020